These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17905235)

  • 1. The use of controlled ovarian hyperstimulation (COH) in clinical in vitro fertilization: the role of Georgeanna Seegar Jones.
    Jones HW
    Fertil Steril; 2008 Nov; 90(5):e1-3. PubMed ID: 17905235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteal-phase defect: the role of Georgeanna Seegar Jones.
    Jones HW
    Fertil Steril; 2008 Nov; 90(5):e5-7. PubMed ID: 18001720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Georgeanna Seegar Jones.
    Oransky I
    Lancet; 2005 Apr 23-29; 365(9469):1460. PubMed ID: 15868654
    [No Abstract]   [Full Text] [Related]  

  • 4. Forty years of IVF.
    Niederberger C; Pellicer A; Cohen J; Gardner DK; Palermo GD; O'Neill CL; Chow S; Rosenwaks Z; Cobo A; Swain JE; Schoolcraft WB; Frydman R; Bishop LA; Aharon D; Gordon C; New E; Decherney A; Tan SL; Paulson RJ; Goldfarb JM; Brännström M; Donnez J; Silber S; Dolmans MM; Simpson JL; Handyside AH; Munné S; Eguizabal C; Montserrat N; Izpisua Belmonte JC; Trounson A; Simon C; Tulandi T; Giudice LC; Norman RJ; Hsueh AJ; Sun Y; Laufer N; Kochman R; Eldar-Geva T; Lunenfeld B; Ezcurra D; D'Hooghe T; Fauser BCJM; Tarlatzis BC; Meldrum DR; Casper RF; Fatemi HM; Devroey P; Galliano D; Wikland M; Sigman M; Schoor RA; Goldstein M; Lipshultz LI; Schlegel PN; Hussein A; Oates RD; Brannigan RE; Ross HE; Pennings G; Klock SC; Brown S; Van Steirteghem A; Rebar RW; LaBarbera AR
    Fertil Steril; 2018 Jul; 110(2):185-324.e5. PubMed ID: 30053940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin therapy: a 20th century relic.
    Reindollar RH; Goldman MB
    Fertil Steril; 2012 Apr; 97(4):813-8. PubMed ID: 22463775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
    Kedem A; Tsur A; Haas J; Yerushalmi GM; Hourvitz A; Machtinger R; Orvieto R
    Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
    Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
    Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.
    Seow KM; Lin YH; Huang LW; Hsieh BC; Huang SC; Chen CY; Chen PH; Tzeng CR; Hwang JL
    Gynecol Endocrinol; 2007 Jun; 23(6):338-42. PubMed ID: 17616858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol.
    Orvieto R; Nahum R; Zohav E; Liberty G; Anteby EY; Meltcer S
    Gynecol Endocrinol; 2013 Jan; 29(1):51-3. PubMed ID: 22857268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human menopausal gonadotropin versus highly purified-hMG in controlled ovarian hyperstimulation for in-vitro fertilisation: does purity improve outcome?
    Orvieto R; Meltcer S; Liberty G; Rabinson J; Anteby EY; Nahum R
    Gynecol Endocrinol; 2010 Oct; 26(10):733-5. PubMed ID: 20500109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.
    Palomba S; Falbo A; Di Cello A; Cappiello F; Tolino A; Zullo F
    Fertil Steril; 2011 Nov; 96(5):1128-33. PubMed ID: 21917254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detrimental effects of high-dose gonadotropin on outcome of IVF: making a case for gentle ovarian stimulation strategies.
    Kovacs P; Sajgo A; Kaali SG; Pal L
    Reprod Sci; 2012 Jul; 19(7):718-24. PubMed ID: 22378863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of elevated peak serum progesterone levels.
    Orvieto R; Nahum R; Meltzer S; Liberty G; Anteby EY; Zohav E
    Gynecol Endocrinol; 2013 Sep; 29(9):843-5. PubMed ID: 23802563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of salpingectomy on ovarian response in controlled ovarian hyperstimulation for in vitro fertilization: a reappraisal.
    Almog B; Wagman I; Bibi G; Raz Y; Azem F; Groutz A; Barkan G; Holzer H; Amit A; Tulandi T; Levin I
    Fertil Steril; 2011 Jun; 95(8):2474-6. PubMed ID: 21474129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. History and challenges surrounding ovarian stimulation in the treatment of infertility.
    Beall SA; DeCherney A
    Fertil Steril; 2012 Apr; 97(4):795-801. PubMed ID: 22463773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
    Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
    Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?
    Ren J; Sha A; Han D; Li P; Geng J; Ma C
    Fertil Steril; 2014 Jul; 102(1):75-81. PubMed ID: 24746740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do poor-responder patients benefit from increasing the daily gonadotropin dose during controlled ovarian hyperstimulation for IVF?
    Haas J; Zilberberg E; Machtinger R; Kedem A; Hourvitz A; Orvieto R
    Gynecol Endocrinol; 2015 Jan; 31(1):79-82. PubMed ID: 25223892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.